Publications by authors named "Maria Badillo"

Claim this Profile
A
A sustained reduction in the rate of severe intraventricular hemorrhage in very low birth weight infants: a novel quality improvement project in a large perinatal-neonatal centre in Asia.
Thowfique Ibrahim, Arpan Agarwal, Abdul Alim Abdul Haium, Nirmal Kavalloor Visruthan, Maria Chona Badillo

Front Pediatr· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma.
Charles Gaulin, Preetesh Jain, Ranjit Nair, Swaminathan P Iyer, Hun Ju Lee, Maria Badillo

Leuk Lymphoma· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Maria Badillo

Nat Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HSP90-MYC-CDK9 network drives therapeutic resistance in mantle cell lymphoma.
Fangfang Yan, Vivian Jiang, Alexa Jordan, Yuxuan Che, Yang Liu, Maria Badillo

Exp Hematol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma.
Vivian Changying Jiang, Yang Liu, Junwei Lian, Shengjian Huang, Alexa Jordan, Maria Badillo

J Clin Invest· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial.
Michael L Wang, Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta Nastoupil, Maria Badillo

Lancet Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 in eight municipalities of the Colombian tropics: high immunity, clinical and sociodemographic outcomes.
Evelin Garay, Héctor Serrano-Coll, Ricardo Rivero, Bertha Gastelbondo, Álvaro Faccini-Martínez, María Badillo

Trans R Soc Trop Med Hyg· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma.
Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Holly A Hill, Chi Young Ok, Maria Badillo

J Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma.
Hans C Lee, Lei Feng, Onyeka Oriabure, Vivian Graham, Wendy Chen, Maria Badillo

Am J Hematol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib.
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Chi Young Ok, Lucy Navsaria, Maria Badillo

Am J Hematol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma.
Shaojun Zhang, Vivian Changying Jiang, Guangchun Han, Dapeng Hao, Junwei Lian, Maria Badillo

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy.
Preetesh Jain, Loretta Nastoupil, Jason Westin, Hun Ju Lee, Lucy Navsaria, Maria Badillo

Br J Haematol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma.
Elisabet E Manasanch, Preetesh Jain, Wendy Chen, Onyeka Oriabure, Maria Badillo

Am J Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acalabrutinib: Managing Adverse Events and Improving Adherence in Patients With Mantle Cell Lymphoma.
Maria Badillo, Diana Nava, Maria Rosa, Wendy Chen, Maria Guerrero

Clin J Oncol Nurs· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients.
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, Chi Young Ok, Shaojun Zhang, Maria Badillo

Am J Hematol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma.
Hun J Lee, Jacob L Schmelz, Fred Cramer, Jorge E Romaguera, Maria Badillo

Br J Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL.
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, Chi Young Ok, Krystle Nomie, Maria Badillo

Blood Adv· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma.
Matthew S Ning, Chelsea C Pinnix, Bhavana V Chapman, Jillian R Gunther, Sarah A Milgrom, Maria R Badillo

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma.
Liang Zhang, Yixin Yao, Shaojun Zhang, Yang Liu, Hui Guo, Maria Badillo

Sci Transl Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated stress response and immune cell infiltration in an ibrutinib-refractory mantle cell lymphoma patient following ONC201 treatment.
Jorge E Romaguera, Hun J Lee, Rohinton Tarapore, Varun Prabhu, Joshua Allen, Maria Badillo

Br J Haematol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma.
Hun J Lee, Maria Badillo, Jorge Romaguera, Michael Wang

Br J Haematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib.
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab, Maria Badillo

Br J Haematol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Preetesh Jain, Jorge Romaguera, Samer A Srour, Hun J Lee, Frederick Hagemeister, Maria Badillo

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
Leo Zhang, Krystle Nomie, Hui Zhang, Taylor Bell, Lan Pham, Maria Badillo

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.
Hun Ju Lee, Jorge E Romaguera, Lei Feng, Aakash P Desai, Liang Zhang, Maria Badillo

Oncologist· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis